These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Tzanakis IP; Papadaki AN; Wei M; Kagia S; Spadidakis VV; Kallivretakis NE; Oreopoulos DG Int Urol Nephrol; 2008; 40(1):193-201. PubMed ID: 18193489 [TBL] [Abstract][Full Text] [Related]
6. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. Slatopolsky E; Weerts C; Lopez-Hilker S; Norwood K; Zink M; Windus D; Delmez J N Engl J Med; 1986 Jul; 315(3):157-61. PubMed ID: 3724805 [TBL] [Abstract][Full Text] [Related]
7. [Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients]. Kiss D; Battegay M; Meier C; Lyrer A Schweiz Med Wochenschr; 1990 Mar; 120(9):295-8. PubMed ID: 2315655 [TBL] [Abstract][Full Text] [Related]
8. Calcium carbonate is an effective phosphorus binder in children with chronic renal failure. Andreoli SP; Dunson JW; Bergstein JM Am J Kidney Dis; 1987 Mar; 9(3):206-10. PubMed ID: 3826069 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder. Malberti F; Surian M; Poggio F; Minoia C; Salvadeo A Am J Kidney Dis; 1988 Dec; 12(6):487-91. PubMed ID: 3143260 [TBL] [Abstract][Full Text] [Related]
10. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. Spiegel DM; Farmer B; Smits G; Chonchol M J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314 [TBL] [Abstract][Full Text] [Related]
11. Calcium carbonate powder as a phosphate binder. Miller D; Taber TE; Hegeman TF ASAIO Trans; 1989; 35(3):322-4. PubMed ID: 2597473 [TBL] [Abstract][Full Text] [Related]
12. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)]. Novikov AI Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540 [No Abstract] [Full Text] [Related]
13. Hypothesis: calcium carbonate as phosphate binder--the fallacy of relying on serum phosphorus. Bommer J; Ritz E Nephrol Dial Transplant; 2010 May; 25(5):1703-5. PubMed ID: 20179006 [No Abstract] [Full Text] [Related]
15. RenaGel efficacy in severe secondary hyperparathyroidism. Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746 [TBL] [Abstract][Full Text] [Related]
16. Calcium carbonate in hyperphosphatemia. Mayo M; Middleton RK DICP; 1991 Sep; 25(9):945-7. PubMed ID: 1949973 [No Abstract] [Full Text] [Related]
17. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. Salusky IB; Foley J; Nelson P; Goodman WG N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306 [TBL] [Abstract][Full Text] [Related]
18. [Use of calcium carbonate (CaCO3) as phosphate binder in dialysis patients in long-term follow-up over 3 years]. Sperschneider H; Günther K; Stein G; Marzoll I; Kirchner E Z Urol Nephrol; 1990 Aug; 83(8):449-58. PubMed ID: 2122612 [TBL] [Abstract][Full Text] [Related]
19. Calcium carbonate as an alternative to aluminium hydroxide in maintenance haemodialysis for chronic renal failure. O'Brien A; McParland C; Keogh B Ir Med J; 1987 Feb; 80(2):68-70. PubMed ID: 3557928 [No Abstract] [Full Text] [Related]
20. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis. Meyrier A; Marsac J; Richet G Kidney Int; 1973 Aug; 4(2):146-53. PubMed ID: 4744972 [No Abstract] [Full Text] [Related] [Next] [New Search]